Alembic has got an approval of US Food and Drug Administration (USFDA) for the generic version of arthritis drug Leflunomide. The approval is for 10 mg and 20 mg strengths of Leflunomide tablets.
Leflunomide is prescribed in active, moderate, and severe rheumatoid arthritis and psoriatic arthritis and is sold by French pharmaceutical major Sanofi-Aventis under the brand name Arava.
Alembic is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.
| Company Name | CMP |
|---|---|
| Lodha Developers | 855.85 |
| Dilip Buildcon | 450.15 |
| DLF | 595.85 |
| Oberoi Realty | 1695.70 |
| Ahluwalia Contract(I | 833.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: